Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
6 clinical trials · Condition
◉ Watch Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049) | NRG Oncology | 2021-12-02 |
| NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer (NCT04615013) | M.D. Anderson Cancer Center | 2020-11-23 |
| Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study (NCT04449679) | Thomas Jefferson University | 2020-04-15 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes (NCT04183218) | Mayo Clinic | 2019-09-23 |
| Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326) | M.D. Anderson Cancer Center | 2019-02-19 |
Track Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.